Accumen Partners with AABB and The Society for the Advancement of Patient Blood Management to Discuss the Essential Role of Patient Blood Management During the COVID-19 Pandemic

April 26, 2021

PHOENIX, AZ – APRIL 26, 2021 – Accumen is helping healthcare get better, faster. Accumen announced that it will be co-hosting a webinar entitled “Let’s Not Go Back to Normal – The Essential Role of Patient Blood Management (PBM)” with AABB (formerly the American Association of Blood Banks) and the Society for the Advancement of Patient Blood Management (SABM) at 12 p.m. ET on April 27.

The COVID-19 pandemic has put enormous strain on all aspects of the healthcare system. As people were encouraged to stay at home, blood donations dramatically decreased, increasing existing blood shortages. While many elective surgeries were put on hold early in the pandemic, there was still a substantial demand for donated blood to treat cancer patients, support urgent surgeries, serious accidents, and actively bleeding patients.

Forward thinking hospitals recognized that the pandemic would likely lead to a protracted blood shortage, so they responded by changing protocols, and putting a greater emphasis on PBM.

“Accumen’s PBM team of clinicians, with experience implementing over 350 hospital PBM programs, has been working with clinical stakeholders remotely, sharing meaningful analytics and transfusion mitigation strategies, raising anemia management awareness and helping each organization to conserve its blood supply,” said Joe Thomas, Vice President/General Manager of Clinical Optimization at Accumen and moderator of the webinar.

By employing comprehensive PBM strategies, hospital staff were able to reduce the likelihood that patients would need a blood transfusion. They partnered with patients to manage anemia with other effective and safe approaches, such as novel medications and iron therapies. Forty percent of patients typically arrive for an elective surgery anemic. Additional PBM methods included employing various medications, devices, and techniques to minimize bleeding and blood loss in hospitalized patients. These approaches focused on preserving the patient’s own blood, leaving the limited blood supplies for those who truly needed them.

“COVID-19 has inspired rapid adoption of PBM and now that its advantages are clear, we hope those advances will continue after the pandemic is behind us,” added Mr. Thomas.

He will be joined by webinar co-presenters Claudia Cohn, MD, PhD, Associate Professor in the Department of Laboratory Medicine and Pathology, Director of the Blood Bank Laboratory, and Associate Director of Clinical Laboratories at the University of Minnesota, and Chief Medical Officer at AABB, and Matthew Warner, MD, anesthesiologist, critical care physician, Director of the Preoperative Anemia Program, and Director of the Bloodless Medicine and Surgery Program at the Mayo Clinic. Dr. Warner is also one of the lead authors on SABM’s paper about the essential role that PBM plays in pandemics.1

Drs. Cohn and Warner will address many ways in which hospital and healthcare systems responded to changes in blood availability during the COVID-19 pandemic. They will describe clinical and operational strategies that were applied to deliver safe patient care. They will also identify steps that need to be taken to make comprehensive PBM the standard of care for the US healthcare system going forward.

Interested persons can register or view replay for this complimentary event.


  1. Shander, et al. The Essential Role of PBM in a Pandemic. Anesthesia and Analgesia, Journal of the International Anesthesia Research Society. 2020 Jul;131(1):74-85.

About AABB
AABB is an international, not-for-profit association representing individuals and institutions involved in the fields of transfusion medicine and cellular therapies. The association is committed to improving health through the development and delivery of standards, accreditation and educational programs that focus on optimizing patient and donor care and safety. AABB membership includes physicians, nurses, scientists, researchers, administrators, medical technologists and other health care providers. AABB members are located in more than 80 countries and AABB accredits institutions in more than 50 countries.

About SABM
SABM is an international nonprofit professional society comprised of a network of multidisciplinary healthcare practitioners, scientists, hospitals, and health systems from around the world, all of whom who are dedicated to improving health outcomes, increasing safety, and reducing healthcare costs through the advancement of scientific knowledge and practice in PBM. SABM also has numerous affiliated Patient Blood Management Societies globally, who all share the same vision and aligned goals. SABM has the only organized comprehensive training course in PBM for healthcare professionals, through which hundreds have been educated, and has created clinical and administrative standards for organized PBM programs.

About Accumen Inc.
At Accumen, our focus is helping healthcare get better, faster. Accumen is a technology enabled organization that partners with hospital, health system, commercial laboratory, and payer clients to provide strategic solutions and services that deliver sustainable performance improvements. Our offerings include lab and imaging transformation, consulting, supply chain optimization, lab outreach, 3D post-processing, PBM, test utilization, anemia management, and clinical data exchange. Accumen’s offerings enable our clients to achieve and exceed their cost, quality, and service targets, as well as deliver excellent patient care through evidence-based data and clinical decision support capabilities. Find out more at

Disclaimer: Accumen has no authority, responsibility, or liability with respect to any clinical decisions made by – or in connection with – a provider’s laboratory, patient blood management, or other operations. Nothing herein and no aspect of any services provided by Accumen is intended – or shall be deemed – to subordinate, usurp, or otherwise diminish any providers’ sole authority and discretion with respect to all clinical decision-making for its patients.

Media Contact
Lisa Osborne, CEO
Rana Healthcare Solutions
Phone: 206.992.5245 | Email:

# # #